The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects
NCT ID: NCT01693809
Last Updated: 2012-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
25 participants
INTERVENTIONAL
2012-01-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondarily, it wants to standardize normal values exam VEMPc in otorhinolaryngology service of the hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VESTIBULAR EVOKED MYOGENIC POTENTIALS IN ALTERED GRAVITY
NCT03562676
Steady State Vestibular Evoked Myogenic Potentials
NCT01260077
Fasciculations in Healthy Adults After Consumption of Caffeine: an Ultrasound Study
NCT05977920
Attentional Focus Influence During Cranio-Cervical Flexion Test
NCT03567122
Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers
NCT01900457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Caffeine
Caffeine 420mg, one time
Caffeine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caffeine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* caffeine abuse 24 hours before the test
* medication remains
* hypertension, dyslipidemia, diabetes mellitus or sleep disorders.
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital do Servidor Publico Estadual
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Maria Almeida de Sousa
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabio Akira Suzuki, PhD
Role: STUDY_CHAIR
Hospital do Servidor Publico Estadual
Ana Maria Almeida Sousa, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital do Servidor Publico Estadual
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital do Servidor Publico Estadual
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0127/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.